{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-031828","form_type":"8-K","ticker":"NUWE","cik":"0001506492","company_name":"Nuwellis, Inc.","filed_at":"2025-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.162672+00:00","generated_at":"2026-05-17T11:25:46.352938+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Nuwellis enters non-binding LOI to acquire Rendiatech, an Israeli renal monitoring firm","bullets":["Rendiatech specializes in real-time urine flow and acute kidney injury monitoring technologies.","Acquisition intended to expand Nuwellis' platform beyond ultrafiltration into continuous renal health monitoring.","Parties in due diligence; transaction expected to close in Q4 2025, pending board approval and conditions.","No financial terms disclosed in the non-binding letter of intent."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-031828","json":"https://secwatch.observer/filing/0001140361-25-031828.json","markdown":"https://secwatch.observer/filing/0001140361-25-031828.md","text":"https://secwatch.observer/filing/0001140361-25-031828.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506492/000114036125031828/0001140361-25-031828-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506492/000114036125031828/ef20054176_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:25:46.352938+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}